NasdaqCM - Nasdaq Real Time Price
USD
InMed Pharmaceuticals Inc. (INM)
1.6000
-0.0250
(-1.54%)
At close: October 30 at 4:00:00 PM EDT
1.5600
-0.0400
(-2.50%)
Overnight: 2:39:59 AM EST
This price reflects trading activity during the overnight session on the Blue Ocean ATS, available 8 PM to 4 AM ET, Sunday through Thursday, when regular markets are closed.
Loading chart for INM
- Previous Close
1.6250 - Open
1.5500 - Bid 1.3300 x 1000
- Ask 1.7100 x 200
- Day's Range
1.5100 - 1.6100 - 52 Week Range
0.5750 - 2.3300 - Volume
36,077 - Avg. Volume
66,681 - Market Cap (intraday)
8.79M - Beta (5Y Monthly) 0.99
- PE Ratio (TTM)
-- - EPS (TTM)
-2.8400 - Earnings Date (est.) Nov 5, 2026
- Forward Dividend & Yield -- (0.00%)
- Ex-Dividend Date --
- 1y Target Est
--
Recent News
View MorePerformance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
INM
50.94%
S&P 500 (^GSPC)
10.73%
1-Year Return
INM
13.51%
S&P 500 (^GSPC)
11.11%
3-Year Return
INM
84.31%
S&P 500 (^GSPC)
81.91%
5-Year Return
INM
99.79%
S&P 500 (^GSPC)
64.59%
Earnings Trends
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-66.46%
-
Return on Equity (ttm)
-156.77%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-11.8M
-
Diluted EPS (ttm)
-2.8400
Balance Sheet and Cash Flow
-
Total Cash (mrq)
2.23M
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-3.19M
